نتائج البحث

Reconsidering the ejection fraction centric view of pharmacologic treatment for heart failure

• Authors : João Pedro Ferreira; Milton Packer; Javed Butler ...

Subjects: Heart Failure; [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system; Humans

• Source: European Journal of Heart FailureEuropean Journal of Heart Failure, European Society of Cardiology (Wiley), 2022,

تفاصيل العنوان

Concentration‐dependent clinical and prognostic importance of high‐sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR ‐Reduced trial

• Authors : Stuart J. Pocock; Daniel Cotton; Martina Brueckmann ...

Subjects: medicine.medical_specialty; New York Heart Association Class; Empagliflozin

• Source: European Journal of Heart FailureEuropean Journal of Heart Failure, European Society of Cardiology (Wiley), 2021, 23 (9),

تفاصيل العنوان

Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER-like endpoint definitions

• Authors : Stefan D. Anker; Tariq Jamal Siddiqi; Gerasimos Filippatos ...

Subjects: Heart Failure with preserved ejection fraction; Heart Failure; [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system

• Source: European Journal of Heart FailureEuropean Journal of Heart Failure, 2022, 24 (8), pp.1400-1405. ⟨10.1002/ejhf.2558⟩

تفاصيل العنوان

Practical algorithms for early diagnosis of heart failure and heart stress using NT‐proBNP: A clinical consensus statement from the Heart Failure Association of the ESC.

• Authors : Bayes‐Genis, Antoni¹ (AUTHOR) ; Docherty, Kieran F.² (AUTHOR); Petrie, Mark C.² (AUTHOR)

• Source: European Journal of Heart Failure. Nov2023, Vol. 25 Issue 11, p1891-1898. 8p.

تفاصيل العنوان

Residual risk in heart failure and the need for simultaneous implementation and innovation.

• Authors : Fatima, Kaneez¹ (AUTHOR); Butler, Javed^2,3 (AUTHOR); Fonarow, Gregg C.⁴ (AUTHOR)

• Source: European Journal of Heart Failure. Sep2023, Vol. 25 Issue 9, p1477-1480. 4p. 2 Graphs.

تفاصيل العنوان

Implementation of sodium–glucose cotransporter 2 inhibitors for heart failure with reduced ejection fraction: Where we are versus where we need to be.

• Authors : Pierce, Jacob B.¹ (AUTHOR); Butler, Javed^2,3 (AUTHOR); Greene, Stephen J.^4,5 (AUTHOR)

• Source: European Journal of Heart Failure. Sep2023, Vol. 25 Issue 9, p1659-1662. 4p. 1 Graph.

تفاصيل العنوان

Artificial intelligence and heart failure: A state‐of‐the‐art review.

• Authors : Khan, Muhammad Shahzeb¹ (AUTHOR) ; Arshad, Muhammad Sameer² (AUTHOR); Greene, Stephen J.^1,3 (AUTHOR)

• Source: European Journal of Heart Failure. Sep2023, Vol. 25 Issue 9, p1507-1525. 19p. 1 Color Photograph, 1 Diagram, 9 Charts.

تفاصيل العنوان

Baseline characteristics of patients enrolled in the EMPACT‐MI trial.

• Authors : Harrington, Josephine^1,2 (AUTHOR); Udell, Jacob A.³ (AUTHOR); Jones, W. Schuyler^1,2 (AUTHOR)

• Source: European Journal of Heart Failure. Sep2023, Vol. 25 Issue 9, p1708-1715. 8p. 4 Charts, 1 Graph.

تفاصيل العنوان

Similarities and distinctions between acetazolamide and sodium–glucose cotransporter 2 inhibitors in patients with acute heart failure: Key insights into ADVOR and EMPULSE.

• Authors : Packer, Milton^1,2 (AUTHOR) ; Butler, Javed^3,4 (AUTHOR)

• Source: European Journal of Heart Failure. Sep2023, Vol. 25 Issue 9, p1537-1543. 7p. 1 Chart, 1 Graph.

تفاصيل العنوان

Cardiovascular health‐related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ‐C30 questionnaire.

• Authors : Anker, Markus S.^1,2,3,4 (AUTHOR) ; Potthoff, Sophia K.^2,3,4,5 (AUTHOR); Lena, Alessia^1,2,3 (AUTHOR)

• Source: European Journal of Heart Failure. Sep2023, Vol. 25 Issue 9, p1635-1647. 13p. 5 Charts, 3 Graphs.

تفاصيل العنوان